For in vitro diagnostic use. Others CRPHS IVD CRPHS CPS_000086 Cardiac C-Reactive Protein (Latex) High Sensitive 05 950 864 190 5 950 864 190 05950864190 5950864190 05950864190 CRPHS 250Tests cobas c 701 CRPHS 04015630928774 Reagents, kits 250 tests cobas c 701/702 true 08 057 605 190 8 057 605 190 08057605190 8057605190 08057605190 CRPHS, 600T, cobas c pack green CRPHS 07613336121207 Reagents, kits 600 tests cobas c 303/503/703 true 04 628 918 190 4 628 918 190 04628918190 4628918190 04628918190 CRP LX HS, 300Tests, cobas c, Integra CRPHS 04015630921508 Reagents, kits 300 tests COBAS INTEGRA 400 Plus, cobas c 311/501/502 true 05950864500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 11 FF000000067D320E FF000000003BC30E 05950864190 310 cobas c 701 2492 cobas c 702 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 08057605500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 9 FF000000069F000E FF0000000488050E 08057605190 9493 cobas c 303 8481 cobas c 503 10299 cobas c 703 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0004628918190c501 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 13 FF0000000468B20E FF0000000024A80E 04628918190 309 cobas c 501 2324 cobas c 502 308 cobas c 311 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on Roche/Hitachi cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0004628918190COIN CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 10 FF00000004A36A0E FF0000000166CE0E 04628918190 302 COBAS INTEGRA 400 plus 304 COBAS INTEGRA 800 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on COBAS INTEGRA systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en

User profile

Select your user profile

CRPHS

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us